ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.91−0.03 (-3.15%)
Close on Nov 18, 2026Market cap $24.27MP/E –Yield –
ABVC BioPharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ABVC BioPharma's free cash flow for the twelve months ending Dec 31, 2023 was -$4.21M. For fiscal 2023 it was -$4.21M. The highest annual figure on record is -$37.77K in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$4.21M | – |
| FY2022 | Dec 31, 2022 | -$7.52M | – |
| FY2021 | Dec 31, 2021 | -$7.62M | – |
| FY2013 | Sep 30, 2013 | -$37.77K | – |
| FY2012 | Sep 30, 2012 | -$915.47K | – |
| FY2011 | Sep 30, 2011 | -$1.62M | – |
| FY2010 | Sep 30, 2010 | -$1.05M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$430.46K | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$461.16K | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$518.06K | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$3.45M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$3.09M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$2.52M | – |
See a number that looks wrong?